Levetiracetam Hikma

Levetiracetam, the active ingredient in Levetiracetam Hikma, is an antiepileptic presented as an intravenous solution for intravenous use. It is employed to treat epilepsy, including partial and generalized seizures, in patients requiring rapid or controlled seizure management.

GNH USA supplies Levetiracetam Hikma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and health‑care institutions worldwide. The company ensures quality assurance, regulatory compliance and reliable cold‑chain logistics for this IV product.

Levetiracetam is an antiepileptic that acts on seizure activity in the central nervous system.

Epilepsy: provides overall seizure control in patients with various seizure types. Partial seizures: reduces frequency and severity of focal seizures. Generalized seizures: helps achieve control of tonic‑clonic and other generalized seizure events.

Levetiracetam may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Dizziness - Fatigue - Headache

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Stevens‑Johnson syndrome - Suicidal thoughts or behavior

When using Levetiracetam, clinicians should consider several safety measures and monitoring requirements. - Renal impairment: adjust dosing as needed based on renal function. - Hepatic dysfunction: monitor liver enzymes and adjust therapy if required. - Pregnancy: use only if potential benefits outweigh potential risks. - Concomitant CNS depressants: monitor for additive sedation or respiratory depression. - Monitor for behavioral changes: watch for irritability, aggression, or mood swings. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levetiracetam can affect or be affected by other medicines, requiring attention to potential interactions.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma concentrations. - Phenobarbital: may lower levetiracetam levels. - Phenytoin: may decrease levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Alcohol: may increase central nervous system depression. - Other antiepileptics: may require dose adjustments for optimal seizure control. - Renal excretion inhibitors: monitor renal function and consider dose modification.